GUIDE — LONGEVITY

Vascular Age: How to Measure and Reduce Your Cardiovascular Age

Dr. Regina Druz, MD, MBA, FACC, FMCP-M·Reviewed May 2026·6 min read
Quick summary

Vascular age measures how old your arteries actually function compared to your chronological age — it can be 10–20 years older or younger than the number on your birth certificate. Testing methods include coronary artery calcium (CAC) scoring, carotid intima-media thickness (CIMT), pulse wave velocity, and VO2 max. Most people do not know their vascular age. Knowing it is the foundation of personalized cardiovascular risk management.

What Is Vascular Age and Why Does It Matter?

Your chronological age tells you how long you’ve been alive. Your vascular age tells you how your arteries are actually performing — how stiff they are, how much plaque has accumulated, and how efficiently your heart is working. The gap between the two is where cardiovascular risk lives.

Someone who is 50 years old chronologically may have arteries that function like a 40-year-old (lower risk, more interventional runway) or like a 65-year-old (significantly elevated risk, requiring aggressive management). Standard cardiology relies primarily on risk calculators that use age as an input but do not actually measure arterial age. Advanced testing does.

How to Measure Your Vascular Age

Coronary Artery Calcium (CAC) Score

The CAC score is a low-radiation CT scan that quantifies calcium deposits in the coronary arteries. It is the single most powerful predictor of future cardiovascular events beyond traditional risk factors. A score of 0 in a patient over 50 is remarkably reassuring — it places them in a very low-risk category even if they have elevated LDL. A high CAC score reclassifies risk upward and typically changes treatment intensity. Every patient over 40 at moderate risk should have a CAC score.

Carotid Intima-Media Thickness (CIMT)

CIMT is an ultrasound measurement of the thickness of the carotid artery wall — a direct proxy for atherosclerosis burden. It is non-invasive, non-radiation, and shows arterial wall changes earlier than calcium scoring in some patients. Abnormal CIMT predicts cardiovascular events independently of standard risk factors. It also provides a visual representation of arterial age that many patients find highly motivating for lifestyle change.

VO2 Max

VO2 max — maximal oxygen uptake — is the single strongest predictor of all-cause mortality and cardiovascular mortality in multiple large studies, stronger than smoking, hypertension, or diabetes. It reflects the integrated performance of the heart, lungs, circulation, and skeletal muscle. Low VO2 max is now classified as a clinical risk factor at Holistic Heart Centers. Improving it through aerobic exercise is one of the most powerful cardiovascular interventions available.

Advanced Biomarker Panel

Beyond imaging, vascular age is reflected in the blood. Advanced lipid panels (ApoB, Lp(a), LDL particle number and size), inflammatory markers (hsCRP, MPO, Lp-PLA2), oxidative stress markers, and metabolic markers (insulin, HOMA-IR) all contribute to a comprehensive picture of vascular biology. The HeartWell Toolkit panels are designed to capture this full picture in one draw.

How Genetics Affects Vascular Age

Cardiovascular risk is both genetic and environmental — but the genetic component is more complex than a single family history question. Key genetic variants affecting vascular age:

  • Lp(a) — the most underdiagnosed genetic risk factor: Lp(a) is almost entirely genetically determined. High Lp(a) (above 50 mg/dL or 125 nmol/L) significantly accelerates atherosclerosis and aortic valve disease. It does not respond to statins or diet. Every person should know their Lp(a) level.
  • FH (Familial Hypercholesterolaemia): Autosomal dominant condition causing severe LDL elevation from birth. Significantly underdiagnosed. Patients with untreated FH have a 3–4× higher risk of premature coronary disease.
  • APOE genotype: APOE-4 carriers have accelerated lipid-related atherosclerosis and higher Alzheimer’s risk. Dietary fat composition recommendations differ for APOE-4 carriers.
  • MTHFR variants: Affect homocysteine metabolism. High homocysteine is an independent cardiovascular risk factor addressable with B vitamins.

How to Decrease Your Vascular Age

Vascular age is not fixed. These interventions have the strongest evidence for reversing or slowing arterial aging:

  • Zone 2 aerobic training 4–5×/week: The most powerful single intervention for VO2 max, endothelial function, and arterial stiffness. 30–45 minutes at conversational pace. Consistent and boring is better than intense and sporadic.
  • Aggressive LDL and inflammation reduction: Every 10 mg/dL reduction in LDL slows CAC progression. High-sensitivity CRP above 2.0 predicts adverse events independently of LDL. Both targets require combined lifestyle and pharmacological strategy in high-risk patients.
  • Blood pressure optimisation: Target systolic below 120 mmHg in high-risk patients — not just below 140. SPRINT trial data shows significant event reduction at lower targets.
  • Sleep quality: Restorative sleep is when vascular repair occurs. Untreated sleep apnoea is incompatible with meaningful cardiovascular risk reduction.
  • Vitamin K2 + D3: K2 activates matrix Gla-protein which inhibits arterial calcification. In patients with established CAC, K2 supplementation (MK-7 form, 100–200 mcg/day) should be considered alongside adequate D3.

Frequently asked questions

At what age should I get my vascular age tested?+

For patients with cardiovascular risk factors (family history, hypertension, high cholesterol, diabetes, smoking history), testing at age 40–45 is appropriate. For those without risk factors, age 45–50 is a reasonable starting point. Waiting until symptoms appear means the disease has had decades to progress silently.

Is a coronary calcium score the same as a CT angiogram?+

No. A CAC score is a low-radiation scan that counts calcium deposits — it does not require contrast dye and takes about 10 minutes. A CT coronary angiogram (CTCA) uses contrast to visualise the actual lumen of the arteries and detect soft plaque. CAC is the appropriate first-line screening test; CTCA is used when intermediate or high risk requires more detailed assessment.

Can you reverse a high coronary calcium score?+

Calcified plaque does not dissolve. However, aggressive risk factor management slows CAC progression significantly and can reduce the inflammatory, lipid-rich, unstable components of plaque — the components that cause heart attacks. A stable, non-progressing CAC score in a treated patient is a meaningful clinical success, even if the number does not go to zero.

Does my family history mean I will definitely get heart disease?+

No. Genetic predisposition is a risk factor, not a destiny. The APOE-4 genotype, Lp(a) elevation, and family history of premature coronary disease all raise risk, but they are not deterministic. Knowing your genetic risk allows you to intervene earlier and more aggressively on modifiable factors. Many patients with high genetic risk outlive their family members by decades because of informed management.

What is the difference between CAC and CIMT?+

CAC measures calcium in the coronary (heart) arteries and is the strongest predictor of coronary events. CIMT measures wall thickness in the carotid (neck) arteries and provides an earlier window into atherosclerosis development. They measure different aspects of the same process. In Dr. Druz’s protocol, both are used because they provide complementary information — CAC for coronary-specific risk stratification, CIMT for overall atherosclerosis burden and treatment monitoring.

References

  1. Detrano R, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups (MESA). N Engl J Med 2008;358(13):1336–1345.
  2. Ross R, et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign. Circulation 2016;134(24):e653–e699.
  3. SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373(22):2103–2116.
  4. Tsimikas S. A test in context: lipoprotein(a). J Am Coll Cardiol 2017;69(6):692–711.
Medical disclaimer

This guide is for educational purposes only and does not constitute medical advice. Always consult a qualified physician before making changes to your diet, exercise, or health management, particularly if you have existing cardiovascular conditions or are taking medications.

Medically reviewed by Dr. Regina Druz, MD, MBA, FACC, FMCP-M — Board-Certified Integrative Cardiologist at Holistic Heart Centers, Roslyn, NY. Last reviewed: May 2026.

Want a Personalized Plan?

Dr. Druz reviews your full cardiovascular profile and builds a personalized protocol — including nutrition, supplementation, and lifestyle strategies specific to your biology.